Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors

Khaled Greish1, Koji Araki, Daqing Li

  • 1Departments of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah 84112, USA.

Biomacromolecules
|September 3, 2009
PubMed

Insights

Silk-elastinlike protein polymer (SELP) hydrogels improve adenoviral gene therapy for head and neck cancer. SELP hydrogels enhance gene expression and reduce tumor volume by controlling viral delivery.

Area of Science:

  • Biotechnology
  • Biomaterials Science
  • Oncology

Background:

  • Gene therapy faces challenges with vector dissemination, transient expression, and rapid clearance.
  • Adenoviral vectors are promising for gene therapy but require improved delivery methods.

Purpose of the Study:

  • To investigate the impact of silk-elastinlike protein polymer (SELP) hydrogels on adenoviral vector biodistribution and anticancer efficacy.
  • To evaluate SELP hydrogels as a localized delivery system for head and neck cancer gene therapy.

Main Methods:

  • Adenovirus carrying reporter genes (Ad-LacZ, Ad-Luc) and therapeutic gene (Ad-Tk) were evaluated in (nu/nu) mice with head and neck cancer.
  • SELP hydrogel concentrations were varied to assess their effect on viral gene expression and biodistribution.
  • Antitumor efficacy was assessed using the Ad-Tk and ganciclovir (GSV) combination therapy within SELP hydrogels.

Main Results:

  • SELP (4 wt %) hydrogels localized viral release and minimized dissemination to the liver.
  • Reporter gene expression was enhanced by 4-8 fold in SELP matrices compared to virus alone.
  • The combination of SELP-Ad-Tk with GSV significantly reduced tumor volume compared to virus alone.

Conclusions:

  • SELP hydrogels offer temporal and spatial control for adenoviral gene delivery to head and neck tumors.
  • SELP hydrogels represent a promising strategy to overcome key obstacles in adenoviral gene therapy.
  • This approach enhances therapeutic efficacy and minimizes off-target effects for cancer treatment.